EUVIMEDEUVIMED entdecken
Crossref

Dendritic cell-expressed IDO alleviates atherosclerosis by expanding CD4+CD25+Foxp3+Tregs through IDO-Kyn-AHR axis

Fengge Wang, Meng Liu, Dan Ma, Zecheng Cai, Lei Liu, Juncheng Wang, Wenjie Zhang, Lin Zhao, Chengfeng Zhai, Yuekang Xu

International Immunopharmacology · 2023-03 · 116 · 109758

DOI: 10.1016/j.intimp.2023.109758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023-03. Verfasst von Fengge Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Provincial Key Laboratory for Conservation and Exploitation of Biological Resources, School of Life Science, Anhui Normal University, Wuhu, Anh…. Hauptthemen laut MEDLINE: Kynurenine, Atherosclerosis. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is a chronic inflammatory disease, in which immune disorders constitute an essential part of vascular pathogenesis. Accumulating evidence indicates that dendritic cells (DCs) and their tryptophan metabolisms regulate host immune responses. However, the mechanistic involvement of metabolic products from DCs in dysregulating vascular immunity during the development of atherosclerosis is far from clear. Flow cytometry examination showed immune cells were accumulated and gradually increased in the atherosclerotic lesions during the atherosclerosis progression, in which IDO+DCs were enriched. To study the role of DC-expressed IDO in the development of atherosclerosis, we made a stable IDO-overexpressing DC line (IDOoeDCs) by lentiviral infection for adoptive transfer into pro-atherosclerotic mice. Compared with DCs containing empty vector (VectorCtrlDC)-treated group, treatment of IDOoeDCs led to a significant reduction of atherosclerotic lesions in the aorta, with decreased aortic infiltration of Th1 immune cells and reduced vascular inflammation. Importantly, IDOoeDCs increased aortic kynurenine (Kyn) concentration and aryl hydrocarbon receptor (AHR) expression, concomitant with CD4+CD25+Foxp3+Treg expansion in the aortic tissues, which were abrogated by AHR antagonist treatment. These results indicate that DC-expressed IDO reduces atherosclerotic lesions by inducing aortic CD4+CD25+Foxp3+Treg expansion through IDO-Kyn-AHR axis, which may represent a novel possibility for treatment or prevention of atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KynurenineAtherosclerosisMiceAnimalsReceptors, Aryl HydrocarbonT-Lymphocytes, RegulatoryDendritic CellsIndoleamine-Pyrrole 2,3,-DioxygenaseForkhead Transcription Factors

Stichwörter der Autor:innen

Aryl hydrocarbon receptorAtherosclerosisDendritic cellsIndoleamine 2, 3-dioxygenaseKynurenineRegulatory T cells

Substanzen

KynurenineReceptors, Aryl HydrocarbonIndoleamine-Pyrrole 2,3,-DioxygenaseFoxp3 protein, mouseForkhead Transcription Factors

Autor:innen und Institutionen

  • Anhui Provincial Key Laboratory for Conservation and Exploitation of Biological Resources, School of Life Science, Anhui Normal University, Wuhu, Anhui 241000, China; Anhui Province Key Laboratory of Active Biological M…
  • Anhui Provincial Key Laboratory for Conservation and Exploitation of Biological Resources, School of Life Science, Anhui Normal University, Wuhu, Anhui 241000, China.
  • Anhui Province Key Laboratory of Active Biological Macro-molecules, Anhui Provincial Engineering Research Center for Polysaccharide Drugs, Wannan Medical College, Wuhu, Anhui 241000, China.
  • Anhui Provincial Key Laboratory for Conservation and Exploitation of Biological Resources, School of Life Science, Anhui Normal University, Wuhu, Anhui 241000, China. Electronic address: yuekang.xu@hotmail.com.

Zitieren

APA

Wang, F., Liu, M., Ma, D., Cai, Z., Liu, L., Wang, J., Zhang, W., Zhao, L., Zhai, C., & Xu, Y. (2023). Dendritic cell-expressed IDO alleviates atherosclerosis by expanding CD4+CD25+Foxp3+Tregs through IDO-Kyn-AHR axis. International Immunopharmacology, 116, 109758. https://doi.org/10.1016/j.intimp.2023.109758

Vancouver

Wang F, Liu M, Ma D, Cai Z, Liu L, Wang J, et al. Dendritic cell-expressed IDO alleviates atherosclerosis by expanding CD4+CD25+Foxp3+Tregs through IDO-Kyn-AHR axis. International Immunopharmacology. 2023;116:109758. doi:10.1016/j.intimp.2023.109758

BibTeX
@article{Wang2023,
  author = {Wang, Fengge and Liu, Meng and Ma, Dan and Cai, Zecheng and Liu, Lei and Wang, Juncheng and Zhang, Wenjie and Zhao, Lin and Zhai, Chengfeng and Xu, Yuekang},
  title = {Dendritic cell-expressed IDO alleviates atherosclerosis by expanding CD4+CD25+Foxp3+Tregs through IDO-Kyn-AHR axis},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {116},
  pages = {109758},
  doi = {10.1016/j.intimp.2023.109758}
}
Kostenlos starten →